<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 19 Apr 2021 17:23:14 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>93个独家中药保护品种卖出200亿！步长、片仔癀成功突围，丽珠大爆发</title><link>https://mp.weixin.qq.com/s/6MGJacFhLXjtP3JQdrKlaw</link><description></description><content:encoded><![CDATA[93个独家中药保护品种卖出200亿！步长、片仔癀成功突围，丽珠大爆发]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>【重磅】恒瑞新药瞄准这个70亿市场，齐鲁、科伦喜提新品</title><link>https://mp.weixin.qq.com/s/rv0GoPD-NYoNm1x6kOkAwQ</link><description></description><content:encoded><![CDATA[【重磅】恒瑞新药瞄准这个70亿市场，齐鲁、科伦喜提新品]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>【焦点】济川将拿下30亿注射剂，奥赛康份额火箭式上涨</title><link>https://mp.weixin.qq.com/s/i0infxqB-TMbAyhQ_4SpPw</link><description></description><content:encoded><![CDATA[【焦点】济川将拿下30亿注射剂，奥赛康份额火箭式上涨]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>【火爆】暴涨195%的抗血栓药，这家湖南药企获批了</title><link>https://mp.weixin.qq.com/s/BvU3lC4cREF_wrav1nn0mQ</link><description></description><content:encoded><![CDATA[【火爆】暴涨195%的抗血栓药，这家湖南药企获批了]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:27:31 +0800</pubDate></item><item><title>再鼎医药：我们不追风，我们就是风</title><link>https://mp.weixin.qq.com/s/SsJ1Zntxl8hh9q2JzamD-A</link><description></description><content:encoded><![CDATA[再鼎医药：我们不追风，我们就是风]]></content:encoded><pubDate>Sun, 18 Apr 2021 07:48:43 +0800</pubDate></item><item><title>6连跌市值蒸发超500亿，“医药股一哥”易主！知名药企被中纪委点名，丽珠1.2亿拿下重磅新药</title><link>https://mp.weixin.qq.com/s/fy455537Ilols9ogD7gahw</link><description></description><content:encoded><![CDATA[6连跌市值蒸发超500亿，“医药股一哥”易主！知名药企被中纪委点名，丽珠1.2亿拿下重磅新药]]></content:encoded><pubDate>Sat, 17 Apr 2021 07:57:32 +0800</pubDate></item><item><title>110家药企晒一季度成绩单！18家扭亏，52家翻倍，长春高新、华润三九……净利润超5亿</title><link>https://mp.weixin.qq.com/s/mcaqMHdHeTLeYMFCEwhITg</link><description></description><content:encoded><![CDATA[110家药企晒一季度成绩单！18家扭亏，52家翻倍，长春高新、华润三九……净利润超5亿]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>【瞩目】科伦冲击辉瑞$53亿大品种！抗感染药首家过评、滴眼液获批</title><link>https://mp.weixin.qq.com/s/P2y4YSMN1NC4-YOPiK2E2A</link><description></description><content:encoded><![CDATA[【瞩目】科伦冲击辉瑞$53亿大品种！抗感染药首家过评、滴眼液获批]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>【重磅】官宣！网售处方药“开闸”</title><link>https://mp.weixin.qq.com/s/qo4945HBCudv-phxl6I9lQ</link><description></description><content:encoded><![CDATA[【重磅】官宣！网售处方药“开闸”]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>【获批】石四药拿下超10亿吸入剂！阿斯利康再迎劲敌</title><link>https://mp.weixin.qq.com/s/wmBrDN3TMLk0NNoX_c67UQ</link><description></description><content:encoded><![CDATA[【获批】石四药拿下超10亿吸入剂！阿斯利康再迎劲敌]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:27:22 +0800</pubDate></item><item><title>齐鲁开挂了！拿下两大重磅品种，64个过评品种霸屏，10个拟集采品种蓄势待发</title><link>https://mp.weixin.qq.com/s/6D56VwgIO1OGn_Y-zuCVEg</link><description></description><content:encoded><![CDATA[齐鲁开挂了！拿下两大重磅品种，64个过评品种霸屏，10个拟集采品种蓄势待发]]></content:encoded><pubDate>Thu, 15 Apr 2021 16:25:19 +0800</pubDate></item><item><title>【重磅】第五批集采目录流出！2款超35亿造影剂上榜，恒瑞、扬子江市场遭冲击</title><link>https://mp.weixin.qq.com/s/3IXTS0aFHoxkLf5NwE6Q9g</link><description></description><content:encoded><![CDATA[【重磅】第五批集采目录流出！2款超35亿造影剂上榜，恒瑞、扬子江市场遭冲击]]></content:encoded><pubDate>Thu, 15 Apr 2021 16:25:19 +0800</pubDate></item><item><title>【瞩目】苑东双喜临门！重磅抗凝药、抗乙肝药齐拿下</title><link>https://mp.weixin.qq.com/s/zXQlBJqU1YYCsLbjsFTo1A</link><description></description><content:encoded><![CDATA[【瞩目】苑东双喜临门！重磅抗凝药、抗乙肝药齐拿下]]></content:encoded><pubDate>Thu, 15 Apr 2021 16:25:19 +0800</pubDate></item><item><title>【关注】佛心大药房亲仁、厚鑫店获得佛山市门诊特定病种指定外购药店资质</title><link>https://mp.weixin.qq.com/s/p2FBksRIyL47r79Paapl8Q</link><description></description><content:encoded><![CDATA[【关注】佛心大药房亲仁、厚鑫店获得佛山市门诊特定病种指定外购药店资质]]></content:encoded><pubDate>Thu, 15 Apr 2021 16:25:19 +0800</pubDate></item><item><title>成都倍特发威！将拿下80亿大品种，13款新药、11个首仿来袭，10大“光脚”品种或集采</title><link>https://mp.weixin.qq.com/s/YON-WlyYn6NFnnrl6EjlXQ</link><description></description><content:encoded><![CDATA[成都倍特发威！将拿下80亿大品种，13款新药、11个首仿来袭，10大“光脚”品种或集采]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:06:25 +0800</pubDate></item><item><title>【瞩目】东阳光药1类新药来势汹汹，8款创新药重磅出击</title><link>https://mp.weixin.qq.com/s/Pado0cBmJ9qhcjR3Lu2Fhw</link><description></description><content:encoded><![CDATA[【瞩目】东阳光药1类新药来势汹汹，8款创新药重磅出击]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:06:25 +0800</pubDate></item><item><title>【重磅】$24亿大品种海正将获批，国内销售暴涨170%</title><link>https://mp.weixin.qq.com/s/tFzM5SsXWFdpQdMsQVo07g</link><description></description><content:encoded><![CDATA[【重磅】$24亿大品种海正将获批，国内销售暴涨170%]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:06:25 +0800</pubDate></item><item><title>【关注】每年销售1.3亿盒的降压药，不是外企竟然是他！</title><link>https://mp.weixin.qq.com/s/mTLN1ZmvjYHoG0xCraGfoQ</link><description></description><content:encoded><![CDATA[【关注】每年销售1.3亿盒的降压药，不是外企竟然是他！]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:06:25 +0800</pubDate></item><item><title>豪森、东阳光药、倍特……20个新品冲击市场！龙头喜提1类新药，国采品种暴涨六成</title><link>https://mp.weixin.qq.com/s/a93NoPETkg47e_nT8LsIyA</link><description></description><content:encoded><![CDATA[豪森、东阳光药、倍特……20个新品冲击市场！龙头喜提1类新药，国采品种暴涨六成]]></content:encoded><pubDate>Tue, 13 Apr 2021 16:17:36 +0800</pubDate></item><item><title>【重磅】科伦1类新药大爆发，本月3个重磅密集来袭</title><link>https://mp.weixin.qq.com/s/6lTCj_DcctDWpgCNOVAwVA</link><description></description><content:encoded><![CDATA[【重磅】科伦1类新药大爆发，本月3个重磅密集来袭]]></content:encoded><pubDate>Tue, 13 Apr 2021 16:17:36 +0800</pubDate></item></channel></rss>